Anti-CD40L antibody frexalimab slows new brain lesions in multiple sclerosis

  • Nat Med. 2023 Aug;29(8):1882-1883. doi: 10.1038/d41591-023-00060-4.
Thiago Carvalho
PMID: 37407835 DOI: 10.1038/d41591-023-00060-4
Products